Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
To gain insight into the possible immune targets of antidepressant, we evaluated the expression of several inflammatory mediators in the hypothalamus of rats chronically (28 days) treated with the serotonin selective reuptake inhibitor fluoxetine (5mg/kg, i.p.) or the tricyclic compound imipramine (15 mg/kg, i.p.). We focused our attention on the hypothalamus as it plays a key role in determining many of the somatic symptoms experienced by depressed patients. This brain region, critical also for expression of motivated behaviours, participates in the control of the hypothalamic-pituitary-adrenal axis activity and in stress response as well as coordinates physiological functions such as sleep and food intake that have been found altered in a high percentage of depressed patients. Notably, hypothalamus is a key structure for brain cytokine expression and function as it integrates signals from the neuro, immune, endocrine systems. By means of quantitative Real Time PCR experiments we demonstrated that a chronic treatment with either fluoxetine or imipramine resulted in a reduction of IL-6 and IFN-γ mRNAs and increased IL-4 mRNA expression in the rat hypothalamus. Moreover, we demonstrated that hypothalamic expression of members of IL-18 system was differentially affected by chronic antidepressant treatments. Chronically administered fluoxetine decreased IL-8 and CX3CL1 hypothalamic expression, while a chronic treatment with imipramine decreased p11 mRNA. Our data suggest that a shift in the balance of the inflammation toward an anti-inflammatory state in the hypothalamus may represent a common mechanism of action of both the chronic treatments with fluoxetine and imipramine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 2×
“Brain-derived neurotrophic factor is known to modulate synaptic plasticity, promote neuronal cell survival, and affect adult hippocampal neurogenesis and has been proposed to play a key role in both depression etiopathogenesis and in the therapeutic activity of antidepressants (Alboni et al., 2011b; Krishnan and Nestl…”
BackgroundDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 2×
“…mainly on regions belonging to the limbic system (i.e. hippocampus, prefrontal cortex or amygdala) (Alboni et al., 2010a; Dagyte et al., 2010; Drevets et al., 2008; Duman and Voleti, 2012; Lorenzetti et al., 2009; Prickaerts et al., 2012; Quidé et al., 2012; Xu et al., 2006; Yu and Chen,…”
BackgroundThe antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
Alterations in 5-HT 1B Receptor Function by p11 in Depression-Like States
Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E., Vaugeois, J.-M., Nomikos, G. G., & Greengard, P. (2006) · Science · doi:10.1126/science.1117571 · Cited by 572 · cited 2×
“It has been demonstrated that long-term exposure to TCA increased the expression of p11 in mice cortex (Svenningsson et al., 2006), however, in the hypothalamus of rats chronically treated with imipramine we observed a decrease in the mRNA levels of p11, while the SSRI fluoxetine failed to affect p11 hypothalamic tran…”
BackgroundGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Lorenzetti, V., Allen, N. B., Fornito, A., & Yücel, M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.021 · Cited by 553
IL-4 in the brain: a cytokine to remember
Gadani, S. P., Cronk, J. C., Norris, G. T., & Kipnis, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202246 · Cited by 549 · cited 7×
“In particular, the majority of the data actually available in the literature are focused on IL-10, in fact IL-10KO mice display a depressive-like phenotype with an increased helplessness (Mesquita et al., 2008) and several classes of AD have been shown to increase the levels of IL-10 in depressed patients as well as i…”
BackgroundInfluentialShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370 · cited 1×
“…(Mesquita et al., 2008) and several classes of AD have been shown to increase the levels of IL-10 in depressed patients as well as in animal models of depression (Kenis and Maes, 2002; Kubera 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 IL-4 IL-10 fo ld c ha ng es m R N A et al., 2001; Maes et al., 2005).”
BackgroundInfluentialThe Role of BDNF in Depression on the Basis of Its Location in the Neural Circuitry
Yu, H., & Chen, Z.-Y. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.184 · Cited by 343 · cited 2×
“…mainly on regions belonging to the limbic system (i.e. hippocampus, prefrontal cortex or amygdala) (Alboni et al., 2010a; Dagyte et al., 2010; Drevets et al., 2008; Duman and Voleti, 2012; Lorenzetti et al., 2009; Prickaerts et al., 2012; Quidé et al., 2012; Xu et al., 2006; Yu and Chen, 2011).”
BackgroundKubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Microglia, seen from the CX3CR1 angle
Wolf, Y., Yona, S., Kim, K.-W., & Jung, S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00026 · Cited by 316
Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221 · cited 2×
“, 2006), its production and expression have been shown to be inhibited by fluoxetine both ex vivo and in vitro (Liu et al., 2011; Roumestan et al., 2007; Sacre et al., 2010).”
BackgroundThe glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192 · cited 1×
“…interest in depression first because abnormalities in the functionality of the HPA axis is one of the most consistent clinical symptom of MD (Pariante, 2006, 2009; Zunszain et al., 2011) and second because it is involved in regulating also many of the somatic symptoms experienced by…”
BackgroundWalker, F. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.002 · Cited by 175 · cited 2×
“In the last decade, evidence proposing that inflammation plays a role in the etiopathogenesis of depression has continued to grow (Walker, 2013) and the anti-inflammatory effect of currently prescribed antidepressant medications is now widely acknowledged (Abdel-Salam et al.”
BackgroundThe role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150 · cited 2×
“…cytokines, it was shown that plasma levels of IL-12 were significantly higher in patients suffering from major depression with respect to controls (Lee and Kim, 2006), moreover AD treatment might have exerted immunomodulatory effects through a decrease in the pro-inflammatory cytokine IL-12 in…”
BackgroundReversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens
Alexander, B., Warner-Schmidt, J., Eriksson, T. M., Tamminga, C., Arango-Lievano, M., Ghose, S., Vernov, M., Stavarache, M., Musatov, S., Flajolet, M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001079 · Cited by 140 · cited 2×
“P11 (S100A10) is a member of the S100 family of proteins that intracellularly regulates the trafficking of transmembrane proteins (like 5HT1B receptor), whose role in depression has become subject of recent investigation (Alexander et al., 2010; Svenningsson and Greengard, 2007; Warner-Schmidt et al., 2010).”
Obuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115 · cited 1×
“ADs have been shown to decrease peripheral inflammation through central mechanisms in animal models of nociception and to possess an immunosuppressive effect as demostrated by ex vivo or in vitro approaches (Kubera et al., 2001; Maes et al., 2012; Obuchowicz et al., 2006).”
BackgroundPlasma Interleukin-18 Levels in Patients with Psychiatric Disorders
Kokai, M., Kashiwamura, S.-I., Okamura, H., Ohara, K., & Morita, Y. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203001-00011 · Cited by 67
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons
Alboni, S., Gibellini, L., Montanari, C., Benatti, C., Benatti, S., Tascedda, F., Brunello, N., Cossarizza, A., & Pariante, C. M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000266 · Cited by 35
Self-citation
Cited by
Pan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405
Kopschina Feltes, P., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A., Moriguchi-Jeckel, C. M., & de Vries, E. F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711708 · Cited by 279
“Alboni et al. (2013) demonstrated promising effects with imipramine and fluoxetine.”
BackgroundLiu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119
“SSRI administration can also attenuate CRH, TNF-α, and IL-1β mRNA expression in the hypothalamus after chronic treatments (Alboni et al., 2013).”
BackgroundInfluential
Metadata
- Authors
- Alboni, S., Benatti, C., Montanari, C., Tascedda, F., & Brunello, N.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 721
- Issue
- 1-3
- Pages
- 158-167
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2069174428
- Cited by
- 53
- References
- 25
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.